IGF1 and breast cancer: While the main antitumor effect of tamoxifen is attributed to the much higher binding affinity of endoxifen to ER, the liver mediated effect of tamoxifen may also contribute per se to the drug efficacy given the association between IGF-I levels and breast cancer risk14 or recurrence15.